Hudson Value Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Hudson Value Partners's LLY Position: Q2 2026 in Review
Hudson Value Partners reduced its Eli Lilly (LLY) stake by 0.54% in Q2 2026, selling an estimated $14.3K and leaving 2,587 shares worth $3.1M. The position accounts for 0.78% of the portfolio, ranked #41.
Hudson Value Partners first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 1,533 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Hudson Value Partners held 2,587 shares of Eli Lilly worth $3.1M as of Q2 2026.
- Hudson Value Partners sold 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
- Eli Lilly made up 0.78% of Hudson Value Partners's portfolio in Q2 2026, its #41 holding.
- Hudson Value Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
- 1,533 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Hudson Value Partners's 13F filing for Q2 2026, filed 10 Jul 2026.